✦ LIBER ✦

Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF

✍ Scribed by Uchiyama, Shinichiro; Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Momomura, Shin-ichi; Goto, Shinya; Izumi, Tohru; Koretsune, Yukihiro; Kajikawa, Mariko; Kato, Masaharu; Ueda, Hitoshi; Iekushi, Kazuma; Yamanaka, Satoshi; Tajiri, Masahiro

Book ID: 122171383
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 403 KB
Volume: 23
Category: Article
ISSN: 1532-8511
DOI: 10.1016/j.jstrokecerebrovasdis.2013.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban versus Warfarin in Japanese

Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial

✍ Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Momomura, Shin-ichi; Uch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Rivaroxaban versus warfarin in Japanese

Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial

✍ Matsumoto, Masayasu; Hori, Masatsugu; Tanahashi, Norio; Momomura, Shin-ichi; Uch 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

Rivaroxaban compared with warfarin in pa

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

✍ Graeme J Hankey; Manesh R Patel; Susanna R Stevens; Richard C Becker; Günter Bre 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 252 KB

Net Clinical Benefit of Warfarin in Pati

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study

✍ Friberg, L.; Rosenqvist, M.; Lip, G. Y. H. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 832 KB

Comparative Effectiveness of Dabigatran,

Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation

✍ Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author) 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 781 KB

Comparative Effectiveness of Dabigatran,

Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation

✍ Pink, J. (author);Pirmohamed, M. (author);Hughes, D. A. (author) 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 781 KB